16-288146-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003502.4(AXIN1):c.2565C>T(p.Ile855=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00056 in 1,613,504 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00070 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00054 ( 2 hom. )
Consequence
AXIN1
NM_003502.4 synonymous
NM_003502.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
AXIN1 (HGNC:903): (axin 1) This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain. The encoded protein interacts with adenomatosis polyposis coli, catenin beta-1, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. This protein functions as a negative regulator of the wingless-type MMTV integration site family, member 1 (WNT) signaling pathway and can induce apoptosis. The crystal structure of a portion of this protein, alone and in a complex with other proteins, has been resolved. Mutations in this gene have been associated with hepatocellular carcinoma, hepatoblastomas, ovarian endometriod adenocarcinomas, and medullablastomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 16-288146-G-A is Benign according to our data. Variant chr16-288146-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 721381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.51 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AXIN1 | NM_003502.4 | c.2565C>T | p.Ile855= | synonymous_variant | 11/11 | ENST00000262320.8 | NP_003493.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AXIN1 | ENST00000262320.8 | c.2565C>T | p.Ile855= | synonymous_variant | 11/11 | 1 | NM_003502.4 | ENSP00000262320 | A1 | |
AXIN1 | ENST00000354866.7 | c.2457C>T | p.Ile819= | synonymous_variant | 10/10 | 1 | ENSP00000346935 | P4 | ||
AXIN1 | ENST00000461023.5 | n.5634C>T | non_coding_transcript_exon_variant | 8/8 | 2 | |||||
AXIN1 | ENST00000457798.1 | downstream_gene_variant | 3 | ENSP00000416835 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152194Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
107
AN:
152194
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000889 AC: 223AN: 250900Hom.: 0 AF XY: 0.000839 AC XY: 114AN XY: 135802
GnomAD3 exomes
AF:
AC:
223
AN:
250900
Hom.:
AF XY:
AC XY:
114
AN XY:
135802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000545 AC: 796AN: 1461192Hom.: 2 Cov.: 31 AF XY: 0.000564 AC XY: 410AN XY: 726910
GnomAD4 exome
AF:
AC:
796
AN:
1461192
Hom.:
Cov.:
31
AF XY:
AC XY:
410
AN XY:
726910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000703 AC: 107AN: 152312Hom.: 0 Cov.: 34 AF XY: 0.000765 AC XY: 57AN XY: 74472
GnomAD4 genome
AF:
AC:
107
AN:
152312
Hom.:
Cov.:
34
AF XY:
AC XY:
57
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | AXIN1: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at